Aligos Therapeutics (ALGS)

• Market cap: $59M
• 1 day: -2.84%
• 5 days: 14.46%
• 1 month: 2.79%
• 3 months: -13.38%
• 6 months: 65.46%
• Year to date: -75.94%
• 1 year: -62.45%
• 5 years: -97.95%
• 10 years: -97.42%
• Sector: Healthcare
• Industry: Biotechnology

About: Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Employees: 70